Mitapivat
N-[4-[4-(cyclopropylmethyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
Molecular Identity
Mitapivat
N-[4-[4-(cyclopropylmethyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
PubChem CID: 59634741
2D Structure
Properties
C24H26N4O3S
Molecular Formula
450.60
Molecular Weight
g/mol
450.1726
Exact Mass
Da
1.8
XLogP
Drug-like (Lipinski: < 5)
91
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
6
H-Bond Acceptors
750
Complexity
SMILES
Canonical SMILES
SMILES: C1CC1CN2CCN(CC2)C(=O)C3=CC=C(C=C3)NS(=O)(=O)C4=CC=CC5=C4N=CC=C5Isomeric SMILES
SMILES: C1CC1CN2CCN(CC2)C(=O)C3=CC=C(C=C3)NS(=O)(=O)C4=CC=CC5=C4N=CC=C5Synonyms(20)
Mitapivat1260075-17-9PKR-IN-1AG-3482WTV10SIKHAG3488-Quinolinesulfonamide, N-(4-((4-(cyclopropylmethyl)-1-piperazinyl)carbonyl)phenyl)-N-(4-((4-(Cyclopropylmethyl)-1-piperazinyl)carbonyl)phenyl)-8-quinolinesulfonamidemitapivatumRefChem:58117PK-R Activator AG-348AG 348Red Cell Pyruvate Kinase Activator AG-348n-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamidePKM2 activator 1020
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Mitapivat
Loading drug network...